American National Registered Investment Advisor Inc. continued to hold its position in MetLife, Inc. (NYSE:MET) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,238 shares of the financial services provider’s stock at the end of the second quarter. American National Registered Investment Advisor Inc.’s holdings in MetLife were worth $837,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. increased its position in MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock valued at $3,616,895,000 after buying an additional 66,475,603 shares in the last quarter. Vanguard Group Inc. increased its position in MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock valued at $3,452,559,000 after buying an additional 1,885,246 shares in the last quarter. State Street Corp increased its position in MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock valued at $2,589,297,000 after buying an additional 680,903 shares in the last quarter. Dodge & Cox purchased a new position in MetLife during the fourth quarter valued at about $2,212,814,000. Finally, Geode Capital Management LLC increased its position in MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock valued at $541,427,000 after buying an additional 664,918 shares in the last quarter. 74.51% of the stock is currently owned by hedge funds and other institutional investors.
Shares of MetLife, Inc. (NYSE:MET) traded up 0.02% during mid-day trading on Monday, hitting $55.35. 3,748,712 shares of the company’s stock traded hands. MetLife, Inc. has a 52 week low of $38.87 and a 52 week high of $58.09. The firm has a 50-day moving average of $51.91 and a 200 day moving average of $52.97. The company’s market cap is $59.55 billion.
MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, May 3rd. The financial services provider reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.19. The company had revenue of $16.27 billion for the quarter, compared to analyst estimates of $17.02 billion. MetLife had a negative net margin of 0.95% and a positive return on equity of 7.57%. MetLife’s revenue was down 11.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.20 earnings per share. Equities research analysts predict that MetLife, Inc. will post $5.38 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.89%. MetLife’s dividend payout ratio (DPR) is presently -258.06%.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.com-unik.info/2017/07/17/metlife-inc-nysemet-position-maintained-by-american-national-registered-investment-advisor-inc.html.
Several research analysts have issued reports on MET shares. TheStreet downgraded MetLife from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $62.00 price objective on shares of MetLife in a report on Wednesday, July 12th. Wells Fargo & Company reaffirmed a “buy” rating on shares of MetLife in a report on Monday, March 27th. J P Morgan Chase & Co reduced their price objective on MetLife from $57.00 to $54.00 and set an “overweight” rating on the stock in a report on Monday, April 3rd. Finally, Zacks Investment Research raised MetLife from a “sell” rating to a “hold” rating in a report on Friday, May 5th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $57.03.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.